PIERIS Proteolab
Develops innovative protein-based therapies with strategic partnerships to improve clinical outcomes.
Launch date
Employees
Market cap
CAD30.0m
Enterprise valuation
(CAD6m) (Public information from Sep 2024)
Share price
$16.16 PIRS
Company register number HRB 221043 (München)
Hallbergmoos Bavaria (HQ)
Authorizing premium user...